Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Traveler's diarrhea.

Alexander K C Leung1, William Lane M Robson, H Dele Davies

  • 1Department of Pediatrics, University of Calgary, Alberta Children's Hospital, The Children's Clinic, Calgary, Alberta, Canada.

Advances in Therapy
|October 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression and Correlation Analysis of Neuropeptide Family Members in the Peripheral Blood of Patients with COVID-19.

Current pediatric reviews·2026
Same author

A Narrative Review of Dietary Interventions and Supplementation for the Prevention and Treatment of Atopic Dermatitis.

Current pediatric reviews·2026
Same author

Correction: The future of severe acute respiratory syndrome-coronavirus and coronavirus disease.

World journal of pediatrics : WJP·2026
Same author

Infectious associations in childhood Kawasaki Disease.

Current pediatric reviews·2026
Same author

The EAT Algorithm: A Visual Tool to De-escalate Food Avoidance Anxiety in Parents.

Current pediatric reviews·2026
Same author

Genomic adaptation in group B <i>Streptococcus</i> following intrapartum antibiotic prophylaxis and childbirth.

mBio·2026
Same journal

Correction: Low-Dose Naltrexone: What is the Evidence? A Narrative Review.

Advances in therapy·2026
Same journal

Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study.

Advances in therapy·2026
Same journal

Treatment Patterns and Decision Drivers in Chinese Patients with Locally Advanced Cervical Cancer: Results from a National Physician Survey.

Advances in therapy·2026
Same journal

Matching-Adjusted Indirect Comparison of Tarlatamab for Patients with Platinum-Refractory or Platinum-Resistant Extensive-Stage Small-Cell Lung Cancer.

Advances in therapy·2026
Same journal

Sacral Neuromodulation for Refractory Overactive Bladder: Closing the Gaps in Anatomy, Mechanisms, and Parameter Selection.

Advances in therapy·2026
Same journal

Exploring the Impact of Delivering Allergy Medication as Self-Care on Healthcare Greenhouse Gas Emissions in the United Kingdom.

Advances in therapy·2026
See all related articles

Travelers' diarrhea, often caused by bacteria like E. coli, affects many globetrotters. Prevention through hygiene, safe food choices, and vaccines like Dukoral can significantly reduce risks and illness severity.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Travel Medicine

Background:

  • Travelers' diarrhea (TD) is a frequent gastrointestinal illness affecting 8-50% of travelers, with higher incidence in those visiting developing countries.
  • The primary cause of TD is the ingestion of fecally contaminated food or water, often by bacterial pathogens such as Escherichia coli.
  • Children and travelers from developed to developing countries are at increased risk.

Purpose of the Study:

  • To summarize the epidemiology, common causes, complications, and prevention strategies for travelers' diarrhea.
  • To highlight the importance of pretravel education and available prophylactic measures.

Main Methods:

  • Review of existing literature on travelers' diarrhea.
  • Analysis of incidence rates, causative agents, and risk factors.

Related Experiment Videos

  • Evaluation of treatment and prevention modalities, including vaccines.

    • Main Results:

    • Most TD cases are bacterial, predominantly *E. coli*, occurring within the first two weeks of travel.
    • Dehydration is the most common complication, manageable with oral rehydration solutions.
    • Antimotility agents and antibiotics can reduce illness duration and severity.

    Conclusions:

    • Pretravel education on hygiene and food safety is crucial for minimizing TD episodes.
    • Vaccines such as Dukoral (for enterotoxigenic *E. coli* and *Vibrio cholerae*) and typhoid vaccine are recommended for specific high-risk travel destinations.
    • Integrated prevention strategies, including vaccination and behavioral modifications, are key to managing TD risk.